728x90 반응형 LIST SK 바이오사이언스1 단백질 기반의 백신은 세상을 바꿀 수 있을 것인가? https://www.nature.com/articles/d41586-021-03025-0 A participant in Novavax’s phase III trial receives a jab in early 2021.Credit: Kenny Holston/The New York Times/eyevine Pamela Sherry is eager to become immunized against COVID-19. But she has put off getting a jab. “I believe vaccines work,” she says. “I want the protection.” Yet she is prone to acute immune reactions and has blood circulation.. 2021. 11. 24. 이전 1 다음 320x100 반응형 LIST
